Update to the International Meeting on Emerging Diseases and Surveillance (IMED) community on the latest activities for the BioSense Program redesign and public health syndromic surveillance (PHSS) meaningful use objective.
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Novel Approaches in Public Health Surveillance
1. Novel Approaches in Public Health Surveillance
BioSense Program Redesign, Meaningful Use, and Syndromic Surveillance
International Meeting on Emerging Diseases and Surveillance (IMED)
Session 13: New Surveillance Strategies
Sunday, February 6, 2011: 8:30-10:30 AM
Vienna, Austria – February 4-7, 2011
Taha A. Kass-Hout, MD, MS
Deputy Director for Information Science (Acting) and BioSense Program Manager
Division of Notifiable Diseases and Healthcare Information (DNDHI)
Public Health Surveillance Program Office (PHSPO)
Office of Surveillance, Epidemiology, and Laboratory Services (OSELS)
Centers for Disease Control & Prevention (CDC)
Any views or opinions expressed here do not necessarily represent the views of the CDC, HHS, or any other entity of the United States
government. Furthermore, the use of any product names, trade names, images, or commercial sources is for identification purposes only,
and does not imply endorsement or government sanction by the U.S. Department of Health and Human Services.
Public Health Surveillance Program Office
Office of Surveillance, Epidemiology, and Laboratory Services
2. The Public Health Surveillance Challenge
Surveillance is a global Limitations of
challenge that knows traditional reporting
no borders systems
The importance of Hierarchical lines of
timely detection reporting
Variance across different
countries
Multitude of potential
data sources
Real-world lessons
from SARS and H1N1
4. Next Generation Public Health Surveillance
Automated Healthcare data and informal sources,
Community Engagement, and Artificial Intelligence
Informal sources
Automated healthcare data
(laboratory, immunization,
notifiable conditions, syndromic,
personal health records, …)
5. Limitations of Current Approaches
Can’t mine
all possible sources
all data types
Delay required for searching,
curating and processing
Massive bandwidth and
processing requirements
Resource limited process
(machine and human)
Policies that hinder data
sharing
Little sharing of standards,
“Federal agencies must focus on consolidating existing data
specifications, and lessons centers, reducing the need for infrastructure growth by
learned implementing a “Cloud First” policy for services, and
increasing their use of available cloud and shared services.”
Vivek Kundra, Fed CIO.
7. EHRs and Health Information Exchanges can
Improve Public Health Surveillance
Enhanced Situation Awareness
Syndromic surveillance exploits more elements from the EHR for earlier characterization
• can limit spread of outbreak or monitor severity of pandemics, and reduce morbidity and mortality
Automated collection and reporting encourages more care provider organizations to participate
Timely and More Complete Notifiable Disease Reporting
Studies have shown that electronically based reporting for STDs averages 7.9 days earlier than
spontaneous reporting, allowing:
• 52% increase in treating patients in 2 weeks
• 28% increase in reaching at risk subject by phone
Automation of this task is popular with healthcare provides since it relieves a perceived burden
Better Prevention and Surveillance or Chronic Conditions
Addresses major factors in rising healthcare costs
Data can be used for outcome-based incentives for best practices
Simple ABCDs (Aspirin Therapy, Blood Pressure Screening, Cholesterol Screening, Smoking Cessation, and
Diabetes) Interventions can reduce the number of avoidable deaths
• CDC’s Demonstrating the Preventive Care Value of HIEs (DPCVCHIE) project is using national standards and
capabilities to evaluate the effectiveness of ABCDs interventions
Consistency of Reporting
Reduced Latency
More Completeness of Reporting
8. Example 1: The Distribute Project
President’s Council of Advisors
on Science and Technology
recommended expanded use of
Emergency Department SS data
New CDC Director accustomed to
daily use of ED SS data for
influenza and other situation
awareness in NYC
CDC funded and worked
collaboratively with the Public
Health Informatics Institute
(PHII) to support rapid scale-up
of ISDS Distribute project
Public-access site: http://isdsdistribute.org
10. Distribute: System
Participating Sites (39)
State (26, 67%)
Sub-State (8, 21%)
City (5, 13%)
~67.5 million ED visits
(>140,000 visits/day)
from April 1, 2009 thru
Feb 1, 2010
Buckeridge DL, Brownstein JS, Lober WB, Olson DR, Paladini M, Ross D, Finelli L, Kass-Hout TA, Buehler JW. 2011. The
Distribute Project: Rapid Sharing of Emergency-Department Surveillance Data During the Influenza A/H1N1 Pandemic. In Review.
11. Distribute: Outcome
Buckeridge DL, Brownstein JS, Lober WB, Olson DR, Paladini M, Ross D, Finelli L, Kass-Hout TA, Buehler JW. 2011. The
Distribute Project: Rapid Sharing of Emergency-Department Surveillance Data During the Influenza A/H1N1 Pandemic. In Review.
12. Example 2: BioSense Program
Civilian Hospitals
• ~640 facilities [~12% ED coverage in US, patchy geo
coverage] [Chief complaints: median 24-hour
latency, Diagnoses: median 6 days latency]
• 8 health department sending data from 482
hospitals
• 165 facilities reporting ED data directly to CDC
or a health department
Veterans Affairs and Department of Defense
• ~1400 facilities in 50 states, District of Columbia, and
Puerto Rico [final diagnosis ~2->5 days latency]
National Labs [LabCorp and Quest]
• 47 states, the District of Columbia, and Puerto Rico
[24-hour latency]
Hospital Labs
• 49 hospital labs in 17 states/jurisdictions [24-hours
latency]
Pharmacies
• 50,000 (27,000 Active) in 50 states [24-hour latency]
13. BioSense Program Redesign
Updated Vision: Beyond early detection Beyond syndromic
The goal of the redesign effort is to be able to provide
Nationwide and regional Situation Awareness for all hazards health-related
events (beyond bioterrorism) and to support national, state, and local responses
to those events
Multiple uses to support your public health Situation Awareness; routine public
health practice; and improved health outcomes and public health
Our strategy is to increase BioSense Program participation and
utility and to support local and state jurisdictions’ health
monitoring infrastructure and workforce capacity
Requires collaboration with other CDC Programs and federal agencies
– 7 years of experience dealing with timely healthcare data (Outpatient, ED, Inpatient, Census,
Laboratory, Radiology, Pharmacy, etc.)
– Infrastructure reconfigured for high performance, scalability and Meaningful Use (MUse)
14. BioSense Program Redesign
A 3-Pronged Approach
Building Connecting Sharing
the Base the Dots Information
A User-Centered Approach
15. Technical Expert Panel (TEP)—Current Status
David Buckeridge Judy Murphy
McGill University Aurora Health System
Julia Gunn Marc Paladini
National Association of County NYC Department of Health
and City Health Officials and Mental Hygiene
(NACCHO) Tom Safranek, Lisa Ferland,
Jim Kirkwood Richard Hopkins
Association of State and Council of State and Territorial
Territorial Health Officers Epidemiologists (CSTE)
(ASTHO)
Walter G. Suarez
Denise Love Kaiser Permanente
National Association of Health
Data Organizations (NAHDO)
16. BioSense Program Redesign
Selected Collaborations
Gulf Oil Spill-associated surveillance
AL, FL, LA, MS, TX, NCEH, CDC EOC+
Dengue case detection
Dengue Branch, FL Dept of Health, VA
State-based asthma surveillance
AL Dept of Health, VA, DoD
Non-acute dental conditions
Division of Oral Health, NC DoH, NCDetect
Rabies post-exposure prophylaxis
Poxvirus & Rabies Branch
Influenza-like illness surveillance
Influenza Division
Contribution to Distribute
ISDS
MUse Workgroup
Enhanced analytics methods
https://sites.google.com/site/changepointanalysis
18. BioSense Program Redesign
Stakeholder Involvement
Seeking individuals from
professional
organizations to
participate in redesign
effort
Coordinating presence at Coverage Map
national conferences
Identifying individuals to
update the map on the Requirements Gathering
collaboration site
Disseminating redesign
project information Community Forum
through communication
channels
http://biosenseredesign.org
19. Environmental Scan
The purpose of the environmental scan is to assess current best
practices in surveillance and extract from them requirements to
aid in the BioSense Redesign
Note: The map has been initially populated with public health
jurisdictions' self-reported data obtained through Distribute
21. HDs Readiness for SS MUse
Many State or Community Health Agencies are not
yet prepared to receive the new wave of EHR data
According to TFAH, ASTHO and BioSense Program redesign
ASTHO’s MUSe Readiness Survey, # of States and Territories Responding = 35
22. Stakeholder Input: Summary Hospital
3%
The BioSense Redesign Collaboration Site has been visited State
by a broad range of public health stakeholders from all 43%
jurisdiction levels Local
51%
Most (87%) felt there is value in viewing a regional or national
surveillance picture
National
Value in the BioSense Network 3%
Data sharing across jurisdictions is the most common data analysis requested
The value provided by BioSense is focused on identifying and tracking outbreaks and
understanding disease transmission patterns
While preferences for presenting information changes little during a public health event, the
types of data required do change
Many syndromes or conditions (including bioterrorism-related) need to be captured to
support PH situation awareness
Barriers
There are many barriers to data sharing, including the lack of established policies and
agreements
Lack of funding and workforce deficiencies are the most common infrastructure needs
Lack of tools, skills, and time account for all barriers related to data analysis
Source: Feedback Forum Posts 1-3, Available under “Your Requirements” at: https://sites.google.com/site/biosenseredesign
Total Number of Respondents = 39; September 1 – November 12, 2010
23. Core Processes and EHR Reqs for PH SS
Data Sources Data on emergency
department (ED) and urgent care (UC)
patient visits captured by health
information system and sent to a
public health authority defines the
scope of this recommendation
Surveillance Goal Assessment of
community and population health for
all hazards defines the scope of this
recommendation
Message and Vocabulary Standards
Standards that support current and
continued PHSS improvements, while
maintaining consistency with those
standards required by the CMS EHR
Reimbursement Program define the
scope of this recommendation
ISDS MUse Workgroup: http://syndromic.org/projects/meaningful-use
24. Core Processes and EHR Reqs for PH SS:
Consensus-Driven Development
ISDS MUse Workgroup informed 41 stakeholders commented; ~ 20%
early iterations. Stakeholder input corporations or professional
validated, refined and better organizations
contextualized the 4 EP or Hospital
recommendations. 9 Vendors
20 Public Health
2 Other
25. Core Processes and EHR Reqs for PH SS:
32 Recommended Elements
ISDS MUse Workgroup: http://syndromic.org/projects/meaningful-use
26. Core Processes and EHR Reqs for PH SS:
32 Recommended Elements
ISDS MUse Workgroup: http://syndromic.org/projects/meaningful-use
27. Core Processes and EHR Reqs for PH SS:
32 Recommended Elements
ISDS MUse Workgroup: http://syndromic.org/projects/meaningful-use
28. Acknowledgements
US CDC TEP Members
James Buehler*, Samuel
Groseclose*, Laura Conn*, Seth David Buckeridge*, Julia Gunn,
Foldy*, Nedra Garrett* Jim Kirkwood, Denise Love, Judy
Murphy, Marc Paladini, Tom
Safranek, Lisa Ferland, Richard
RTI International
Hopkins, Walter Suarez
Barbara Massoudi*, Lucia Rojas-
Smith, S. Cornelia Kaydos-
Daniels, Annette Casoglos, Rita
Sembajwe, Dean Jackman, Ross ISDS
Loomis, Alan O'Connor, Taya Charlie Ishikawa*, Anne Gifford,
McMillan, Amanda Flynn, Tonya
Farris, Alison Banger, Robert Rachel Viola, Emily Cain
Furberg
Epidemico
John Brownstein*, Clark Freifeld,
Deanna Aho, Nabarun Dasgupta,
Susan Aman, Katelynn O'Brien
* Co-authors
29. Thank You!
BioSense Redesign ISDS MUse Workgroup
http://biosenseredesign.org http://syndromic.org/projects/meaningful-use
biosense.redesign2010 AT gmail DOT com
Any views or opinions expressed here do not necessarily represent the views of the CDC, HHS, or any other entity of the United States
government. Furthermore, the use of any product names, trade names, images, or commercial sources is for identification purposes only,
and does not imply endorsement or government sanction by the U.S. Department of Health and Human Services.